Press & News

New software will incorporate natural language processing (NLP) for more effective patient screening and follow-up SAN FRANCISCO – October 21,...

Honored for excellence in innovation in cardiovascular & ophthalmic innovations SAN FRANCISCO – April 19, 2024 – Viz.ai, the leader...

Aims to accelerate aortic stenosis detection, reduce health disparities, and improve patient outcomes Viz.ai, the leader in AI-powered disease detection...

Company’s artificial intelligence technology shows 74% reduction in in-hospital mortality rates for pulmonary embolism SAN FRANCISCO – March 7, 2024...

Company’s Artificial Intelligence Technology Shows Better Results in Early Detection and Patient Care SAN FRANCISCO, CA – September 21 –...

Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed...

End-to-end platform for vascular care teams to accelerate the detection and treatment of suspected vascular disease SAN FRANCISCO – January...

Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value. SAN FRANCISCO & NEW YORK--(BUSINESS...

Partnership to accelerate enrollment and diversity in neurovascular clinical research. SAN FRANCISCO - November 16, 2022 -  Viz.ai, the leader in...